The government announces the presidential election will be held on June 3.
The findings were released Thursday by the American Society of Clinical Oncology and will be discussed at its annual meeting in Chicago. The study, funded by the National Institutes of Health, was led by Lucas Mavromatis, a medical student at New York University’s Grossman School of Medicine.“Chronic disease and chronic disease prevention are some of my passions,” said Mavromatis, a former research fellow with an NIH training program.
GLP-1 receptor agonists are injections used to treat diabetes, and some are also approved to treat obesity. They work by mimicking hormones in the gut and the brain to regulate appetite and feelings of fullness. Theyand can produce side effects that include nausea and stomach pain.In the study, researchers analyzed data from 43 U.S. health systems to compare two groups: people with
and diabetes who took GLP-1 drugs and other people with the same conditions who took diabetes drugs like sitagliptin. The two groups were equal in size and matched for other characteristics.After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of diabetes drug. There were 2,501 new cases of obesity-related cancer in the GLP-1 group compared to 2,671 cases in the other group.
The effect was evident in women, but not statistically significant in men. The study couldn’t explain that difference, but Mavromatis noted that differences in blood drug concentration, weight loss, metabolism or hormones could be at play.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.A person got inside the pen in January, and Star began losing weight. In February, someone cut the locks off the pen’s gates and Star wandered downtown streets. The following night, someone sprayed some type of substance into Star’s pen.
Earlier, Whitehead shied away from thinking that person might have poisoned Star, but now he doesn’t know.Star had a persistent cough after the February incidents and then developed pneumonia. It was believed that contents from his stomach were coming up through his nose, and Star breathing that matter back into his lungs caused the pneumonia.
It’s possible Star ate a plastic bag when he was wandering downtown Anchorage, which could cause indigestion problems and chronic weight loss.He was cured of pneumonia but developed a second bout.